Ligand Pharmaceuticals (LGND) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | 35.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.22% |
| Dec 31, 2025 | 89.66% |
| Sep 30, 2025 | -2.80% |
| Jun 30, 2025 | -9.61% |
| Mar 31, 2025 | 6.84% |
| Dec 31, 2024 | 31.52% |
| Sep 30, 2024 | 120.38% |
| Jun 30, 2024 | 53.46% |
| Mar 31, 2024 | 23.66% |
| Dec 31, 2023 | -80.37% |
| Sep 30, 2023 | -45.35% |
| Jun 30, 2023 | -24.13% |
| Mar 31, 2023 | -34.42% |
| Dec 31, 2022 | 180.02% |
| Sep 30, 2022 | 29.15% |
| Jun 30, 2022 | -7.02% |
| Mar 31, 2022 | 7.60% |
| Dec 31, 2021 | 4.34% |
| Sep 30, 2021 | 26.02% |
| Jun 30, 2021 | 38.82% |
| Mar 31, 2021 | 48.68% |
| Dec 31, 2020 | 58.33% |
| Sep 30, 2020 | 22.92% |
| Jun 30, 2020 | 11.99% |
| Mar 31, 2020 | 5.72% |
| Dec 31, 2019 | 4.84% |
| Sep 30, 2019 | 15.12% |
| Jun 30, 2019 | 36.55% |
| Mar 31, 2019 | 17.39% |
| Dec 31, 2018 | -33.22% |
| Sep 30, 2018 | 4.23% |
| Jun 30, 2018 | 4.07% |
| Mar 31, 2018 | -24.65% |
| Dec 31, 2017 | 72.94% |
| Sep 30, 2017 | 6.58% |
| Jun 30, 2017 | -0.52% |
| Mar 31, 2017 | 46.79% |
| Dec 31, 2016 | 76.55% |
| Sep 30, 2016 | 73.62% |
| Jun 30, 2016 | 23.58% |
| Mar 31, 2016 | 41.32% |
| Dec 31, 2015 | 19.07% |
| Sep 30, 2015 | -23.39% |
| Jun 30, 2015 | 24.29% |
| Mar 31, 2015 | 40.98% |
| Dec 31, 2014 | 63.15% |
| Sep 30, 2014 | 141.49% |
| Jun 30, 2014 | 102.82% |
| Mar 31, 2014 | 83.90% |
| Dec 31, 2013 | 59.52% |
| Sep 30, 2013 | 51.33% |
| Jun 30, 2013 | 7.03% |
| Mar 31, 2013 | 58.53% |
| Dec 31, 2012 | 34.89% |
| Sep 30, 2012 | 6.63% |
| Jun 30, 2012 | 14.17% |
| Mar 31, 2012 | 56.86% |
| Dec 31, 2011 | 126.69% |
| Sep 30, 2011 | 70.56% |